trending Market Intelligence /marketintelligence/en/news-insights/trending/spsbrxenumqmwa1031am1g2 content esgSubNav
In This List

Cesca Therapeutics COO to resign from board

Blog

A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research

Blog

2021 Year in Review: Highlighting Key Investment Banking Trends

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021


Cesca Therapeutics COO to resign from board

Vivian Liu plans to resign as a director of Cesca Therapeutics Inc., effective upon the expiration of her term June 22.

Liu will continue to serve as the COO and corporate secretary for Cesca and as a director and executive officer of the company's majority-owned ThermoGenesis Corp. subsidiary.

As result of Liu's resignation, the company's board is expected to vote on decreasing the board's size to five members.

Liu's decision to resign did not involve any disagreements with the company, the management, or the board on any matter relating to operations, policies or practices, according to Cesca Therapeutics.

Rancho Cordova, Calif.-based Cesca Therapeutics develops, commercializes and markets a range of automated technologies and products for cell-based therapeutics.